CVS Health expands West Virginia opioid disposal
CVS Health is bringing medication disposal kiosks to 19 CVS Pharmacy locations in West Virginia. The kiosks, the first in CVS Pharmacy stores, join the five that CVS Health has donated to police departments in the state, and accompany a $20,000 CVS Health Foundation grant to Westbrook Health Services in Parkersburg, W. Va., to support opioid addiction recovery.
“CVS Health is dedicated to addressing and preventing opioid abuse and misuse in the communities we serve,” CVS Health vice president of professional services Thomas Davis said. “We are expanding our safe medication disposal efforts to provide more locations where people can safely dispose of unwanted medications, getting them out of medicine cabinets where they could be abused. Our safe medication disposal initiative, and our funding for community organizations supporting addiction recovery in West Virginia, are an extension of CVS Health’s purpose of helping people on their path to better health.”
Through the more than 850 units that CVS Health has donated to police departments nationwide, it has collected more than 140 metric tons of unwanted medication, the company said.
Grant recipient Westbrook Health Services offer behavioral health services in eight West Virginia counties. CVS Health said the grant will support the organization’s Community Partner Outreach Initiative for Healthy Outcomes, through which it educates and connects people struggling with substance use disorder to community programs and services. The grant will improve training, which will benefit 3,000 patients in Westbrook’s treatment center and 5,000 local students through community outreach, CVS Health said.
“The funding Westbrook Health Services received from CVS Health allows us to provide valuable training in substance use disorder for Westbrook staff and the community at large,” Westbrook marketing coordinator Liz Ford said. “Through this support, we are better able address the opioid epidemic throughout West Virginia, which is critical to delivering a healthier community.”
Sanofi to unload European generics business
Sanofi and Advent International are negotiating the sale of Sanofi’s European generics business Zentiva to the global investment company for €1.9 billion. Advent’s fully financed offer would support Zentiva’s management team to invest in operations, production facilities and research and development capabilities, the companies said.
“Zentiva is a robust business with a highly talented workforce and we believe it has demonstrated its potential for growth,” Sanofi CEO Olivie Brandicourt said. “Following a comprehensive review of strategic options for our generic unit in Europe, we have determined that transferring this business to Advent is the best option to ensure its long-term success.”
Sanofi said that Zentiva is not part of its core business, and the sale is part of its strategy to simplify and reshape the company.
“We have long been attracted to the generics pharmaceutical sector as it enables more people to access high quality treatments by lowering their cost,” said Advent managing director and co-head of its European healthcare team Tom Allen and Advent managing director Cédric Chateau. “We believe that Zentiva is a great platform, full of talented people, who we can invest behind to build a new, independent, European generics leader.”
The companies said they expect the transaction to close by the end of 2018, pending finalization of agreements and regulatory approval.
AmerisourceBergen Foundation donates drug disposal tools
The AmerisourceBergen Foundation has distributed nearly 55,000 drug disposal resources to communities nationwide, the charitable arm of Valley Forge, Pa.-based AmerisourceBergen said Monday. The resources, donated through the AmerisourceBergen Foundation Municipal Support Program, contain ingredients that deactivate opioids when combined with water.
The foundation’s efforts to make disposal of unused medication easier come as a recent Substance Abuse and Mental Health Services Administration Survey found that nearly 40% of people who have misused prescription pain medication obtained them from a friend or relative.
“We are encouraged by the immediate reach and impact of the grant program, and remain steadfast in our commitment to providing the communities where we live and work with the critical resources needed to help drive sustained change and combat the epidemic of opioid misuse,” said Gina Clark, AmerisourceBergen Foundation president and AmerisourceBergen executive vice president and chief communications and administration officer.
The company recently marked the introduction of the resources in the North Carolina cities of Stanley, Belmont, Rutherfordton and Shelby alongside Rep. Patrick McHenry, R.-N.C.
“The opioid epidemic is devastating families and communities all across the country, including western North Carolina,” McHenry said. “We must take action to end this crisis. Collaboration between companies like AmerisourceBergen and local communities like the town of Stanley are crucial in the fight against the opioid epidemic. I am thankful for the efforts of the AmerisourceBergen Foundation and their donation to the town of Stanley and other communities here in the Tenth District as they work to end opioid abuse.”
The AmerisourceBergen Foundation said that in the past several months, it has announced partnerships and grants aimed at providing opioid abuse, misuse and diversion prevention resources. Municipal entities and nonprofits interested in applying for resources can apply here.